Press releases
- dsm-firmenich to sell MEG-3® fish oil business to KD Pharma Group
- dsm-firmenich issues €800 million long-term bond
- DSM shareholders can voluntarily transfer their shares to dsm-firmenich before July 2, 2024, 17:45 hours CEST
- dsm-firmenich announces sale of yeast extract business to Lesaffre
- dsm-firmenich takes strategic actions to strengthen its position as a leading creation and innovation partner in Nutrition, Health and Beauty
- dsm-firmenich implements a cross guarantee agreement to mitigate structural subordination and establish a pari-passu debt platform
- Methane-reducing feed ingredient Bovaer® ready for US market launch
- dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2024
- Share repurchase program to cover share plans completed
- dsm-firmenich Q1 2024 trading update
More ▼
Key statistics
As of last trade DSM-Firmenich AG (DSMFF:QXE) traded at 105.00, -3.49% below its 52-week high of 108.80, set on May 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 105.00 |
---|---|
High | 105.00 |
Low | 105.00 |
Bid | -- |
Offer | -- |
Previous close | 105.00 |
Average volume | -- |
---|---|
Shares outstanding | 265.68m |
Free float | 66.89m |
P/E (TTM) | -- |
Market cap | 29.32bn EUR |
EPS (TTM) | -- |
Annual div (ADY) | 2.70 USD |
---|---|
Annual div yield (ADY) | 2.57% |
Div ex-date | May 09 2024 |
Div pay-date | May 16 2024 |
Data delayed at least 15 minutes, as of Jul 16 2024 15:31 BST.
More ▼